BIOMEDWIRE Companies view mergers and acquisitions (“M&A”) as opportunities to broaden their portfolio, expand to international markets and increase leverage and scale. In the MedTech industry, in particular, companies look at M&A as an opportunity to drive positive financial growth and enhance therapeutic solutions (https://ibn.fm/yqmb6), as well as to address industry changes such as those brought by newly introduced regulations, slowed health care spending, negative pricing trends or, more recently, the pandemic.